Abstract
Epidermal growth factor receptor (EGFR) plays an important role in the progression of malignancy in gliomas. We studied the growth inhibition of the malignant glioma cell lines using an antisense EGFR oligodeoxynucleotide enveloped with LipofectinR. At a concentration of 5 μM of the antisense EGFR oligodeoxynucleotide enveloped with LipofectinR, the proliferation of three malignant glioma cell lines was significantly inhibited (p < 0.05) compared with that of the cells exposed to 5 μM sense EGFR oligodeoxynucleotide. The activity of the tyrosine kinase and the DNA synthesis was also significantly suppressed (p < 0.05). These findings show that the antisense EGFR oligodeoxynucleotide enveloped with LipofectinR has a possibility to become a useful gene therapy against malignant gliomas.
Similar content being viewed by others
References
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147, 1985
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–425, 1984
Greenfield C, Hiles I, Waterfield MD, Federwisch W, Wollmer A, Blundell T, McDonald N: Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J 8: 4115–4123, 1989
Lin CR, Chen WS, Kruiger W, Stolarsky WS, Weber W, Evens EM, Verma IM, Gill GN, Rosenfeld MG: Expression cloning of human EGF receptor complementary DNA; gene amplification and three related messenger RNA products in A431 cells. Science 224: 843–848, 1984
Carpenter G, Zendegui J: Epidermal growth factor its receptor and related proteins. Exp Cell Res 164: 1–10, 1986
Inman WH, Carpenter G: In development and recognition of the transformed cell. In: Green MI, Hamaoka T (eds) Plenum, New York, 111–121, 1987
Hendler FJ, Ozanne BW: Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74: 647–651, 1984
Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JRC, Harris AL: Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet i: 366–368, 1985
Gullick WJ, Marden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD: Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res 46: 285–292, 1986
Xu YH, Richert N, Ito S, Merlino GT, Pastan I: Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81: 7308–7312, 1984
Ekstrand AJ, James CD, Cavenee WK, Selinger B, Pettersson RF, Collins VP: The genes for epidermal growth factor receptor, transforming growth factor — alpha and epidermal growth factor and their expression in human glioblastomas in vivo. Cancer Res 51: 2164–2172, 1991
Sugawa N, Ekstrand AJ, James CD, Collins VP: Identical splicing of aberrant epidermal growth factor receptor transcript from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87: 8602–8606, 1990
Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Masabumi S: Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8: 1816–1820, 1988
Humphrey PA, Wang AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD: Antisynthetic peptide antibody reacting at the fusion junction of delesion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sci USA 87: 4207–4211, 1990
Ekstrand AJ, Sugawa N, James CD, Collins VP: Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N-and/or C-terminal trials. Proc Natl Acad Sci USA 89: 4309–4313, 1992
Arai K, Horie Y, Kurimoto M, Endo S, Hiraga K, Takaku A: A cell line of human malignant astrocytoma producing autocrine growth factor. In vitro cell. Dev Biol 27A: 606–614, 1991
Noonan KE, Roninson IB: mRNA phenotyping by enzy matic amplification of randomly primed cDNA. Nucleic Acids Res 16: 10366, 1988
Packer RJ, Sutton LN, Goldwein JW, Perilongo C, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74(3): 433–440, 1991
Walker MD: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas, a cooperative clinical trial. J Neurosurgery 49: 333–343, 1978
Ekstrand AJ, Longo N, Collins VP, James CD: Functional analysis of an epidermal growth factor receptor with a truncation in the extracellular domain that is frequently produced in glioblastoma with EGFR amplification. J Neuro-Oncol 15(Suppl): S8, 1993
Colomer G, Lupu R, Bacus SS, Gelmann EP: erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification. Br J Cancer 70: 819–825, 1994
Yagi K, Noda H, Kurono M, Ohishi N: Efficient gene transfer with less cytotoxicity by means of cationic multilamellar liposomes. Biochem Biophys Res Commun 196: 1042–1048, 1993
Yagi K, Nishikimi M, Hayashi Y: Incorpolation of histone into liposomes increases the efficiency of liposome-mediated gene transfer. J Clin Biochem Nutr 10: 21–25, 1991
Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727–7731, 1994
Nister M, Libermann T, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin C-H, Schlessinger J, Westermark B: Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-a and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910–3918, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugawa, N., Ueda, S., Nakagawa, Y. et al. An antisense EGFR oligodeoxynucleotide enveloped in lipofectinR induces growth inhibition in human malignant gliomas in vitro. J Neurooncol 39, 237–244 (1998). https://doi.org/10.1023/A:1005903002865
Issue Date:
DOI: https://doi.org/10.1023/A:1005903002865